171 related articles for article (PubMed ID: 31092442)
1. Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer.
Christensen MV; Høgdall C; Jensen SG; Lokman N; Ricciardelli C; Christensen IJ; Christiansen P; Brask J; Karlsen MA; Nissen TK; Jochumsen KM; Høgdall E
Anticancer Res; 2019 May; 39(5):2475-2482. PubMed ID: 31092442
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
Wang J; Zhao S; Wang F; Wang J; Zhang Y
Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2 plays a critical role in epithelial ovarian cancer.
Deng Y; Chen C; Hua M; Xi Q; Liu R; Yang S; Liu J; Zhong J; Tang M; Lu S; Tang C; Wang Y
Arch Gynecol Obstet; 2015 Jul; 292(1):175-82. PubMed ID: 25547062
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B
Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338
[TBL] [Abstract][Full Text] [Related]
7. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
Noye TM; Lokman NA; Oehler MK; Ricciardelli C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
[TBL] [Abstract][Full Text] [Related]
8. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
[TBL] [Abstract][Full Text] [Related]
9. S100A10 as a novel biomarker in colorectal cancer.
Shang J; Zhang Z; Song W; Zhou B; Zhang Y; Li G; Qiu S
Tumour Biol; 2013 Dec; 34(6):3785-90. PubMed ID: 23828264
[TBL] [Abstract][Full Text] [Related]
10. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
11. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma.
Xu L; Guo Y; Xu N; Chen L; Zhu J; Liu N; Zhang ZY
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023965
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy.
Jin L; Shen Q; Ding S; Jiang W; Jiang L; Zhu X
Gynecol Oncol; 2012 Jul; 126(1):140-6. PubMed ID: 22487537
[TBL] [Abstract][Full Text] [Related]
14. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
Luo L; Gao Y; Sun X
Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
[TBL] [Abstract][Full Text] [Related]
15. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
16. High LIN28A and PLK4 co‑expression is associated with poor prognosis in epithelial ovarian cancer.
He Y; Wang H; Yan M; Yang X; Shen R; Ni X; Chen X; Yang P; Chen M; Lu X; Shao G; Zhou X; Shao Q
Mol Med Rep; 2018 Dec; 18(6):5327-5336. PubMed ID: 30365085
[TBL] [Abstract][Full Text] [Related]
17. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
[TBL] [Abstract][Full Text] [Related]
18. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
Zeng Y; Chen M; Ganesh S; Hu S; Chen H
PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768
[TBL] [Abstract][Full Text] [Related]
20. Multiple functions of S100A10, an important cancer promoter.
Saiki Y; Horii A
Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
